Literature DB >> 19180464

A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection.

Amy N Sieve1, Karen D Meeks, Sheetal Bodhankar, Suheung Lee, Jay K Kolls, Jerry W Simecka, Rance E Berg.   

Abstract

Immune responses to pathogens occur within the context of current and previous infections. Cross protection refers to the phenomena where infection with a particular pathogen provides enhanced resistance to a subsequent unrelated pathogen in an antigen-independent manner. Proposed mechanisms of antigen-independent cross protection have involved the secretion of IFN-gamma, which activates macrophages, thus providing enhanced innate immunity against the secondary viral or bacterial pathogen. Here we provide evidence that a primary infection with the chronic respiratory pathogen, Mycoplasma pulmonis, provides a novel form of cross protection against a secondary infection with Listeria monocytogenes that is not mediated by IFN-gamma, but instead relies upon IL-17 and mobilization of neutrophils. Mice infected with M. pulmonis have enhanced clearance of L. monocytogenes from the spleen and liver, which is associated with increased numbers of Gr-1(+)CD11b(+) cells and higher levels of IL-17. This enhanced clearance of L. monocytogenes was absent in mice depleted of Gr-1(+) cells or in mice deficient in the IL-17 receptor. Additionally, both the IL-17 receptor and neutrophils were essential for optimal clearance of M. pulmonis. Thus, a natural component of the immune response directed against M. pulmonis was able to enhance clearance of L. monocytogenes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19180464      PMCID: PMC2735239          DOI: 10.1002/eji.200838726

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  53 in total

1.  Monoclonal antibody NIMP-R10 directed against the CD11b chain of the type 3 complement receptor can substitute for monoclonal antibody 5C6 to exacerbate listeriosis by preventing the focusing of myelomonocytic cells at infectious foci in the liver.

Authors:  J W Conlan; R J North
Journal:  J Leukoc Biol       Date:  1992-07       Impact factor: 4.962

2.  Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors.

Authors:  T K Kishimoto; M A Jutila; E L Berg; E C Butcher
Journal:  Science       Date:  1989-09-15       Impact factor: 47.728

3.  Long-term epidemiology of infections with Mycoplasma pneumoniae.

Authors:  H M Foy; G E Kenny; M K Cooney; I D Allan
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

4.  Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.

Authors:  R F Parker; J K Davis; D K Blalock; R B Thorp; J W Simecka; G H Cassell
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Serum antibody and cellular responses in LEW and F344 rats after immunization with Mycoplasma pulmonis antigens.

Authors:  J W Simecka; G H Cassell
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

6.  Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphonate: effects on antimicrobial resistance.

Authors:  A J Pinto; D Stewart; N van Rooijen; P S Morahan
Journal:  J Leukoc Biol       Date:  1991-06       Impact factor: 4.962

7.  Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice.

Authors:  M K Davidson; J K Davis; J R Lindsey; G H Cassell
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

8.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

9.  Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells.

Authors:  H Rosen; S Gordon; R J North
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

10.  Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium.

Authors:  J W Conlan; R J North
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  20 in total

1.  A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production.

Authors:  Amy N Sieve; Karen D Meeks; Suheung Lee; Rance E Berg
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

2.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease.

Authors:  Sheetal Bodhankar; Xiangle Sun; Matthew D Woolard; Jerry W Simecka
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

Review 3.  Precarious balance: Th17 cells in host defense.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

4.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

5.  Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling.

Authors:  Xiaolun Sun; Deborah Threadgill; Christian Jobin
Journal:  Gastroenterology       Date:  2011-10-01       Impact factor: 22.682

6.  Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.

Authors:  Maximillion T Mize; Xiangle L Sun; Jerry W Simecka
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

7.  Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells.

Authors:  Flávio V Loures; Adriana Pina; Maíra Felonato; Eliseu F Araújo; Katia R M Leite; Vera L G Calich
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Anti-IL-17 therapy restricts and reverses late-term corneal allorejection.

Authors:  Xiao-Tang Yin; Stephanie Zobell; Jason G Jarosz; Patrick M Stuart
Journal:  J Immunol       Date:  2015-03-09       Impact factor: 5.422

9.  Toll-like receptor 2 promotes T helper 17 cells response in hepatitis B virus infection.

Authors:  Rong-Rong Zhao; Xiao-Fei Yang; Jie Dong; Yan-Yan Zhao; Xin Wei; Chang-Xing Huang; Jian-Qi Lian; Ye Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection.

Authors:  Xiaoling Gao; Lei Zhao; Shuhe Wang; Jie Yang; Xi Yang
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.